Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA.
University of Mississippi School of Medicine, Jackson, MS, USA.
Am Surg. 2023 Aug;89(8):3594-3596. doi: 10.1177/00031348231157895. Epub 2023 Mar 15.
Given its mortality benefit, renal transplantation remains the ideal treatment modality for end stage renal disease in children. Despite the recent expansion of use in young children, the novel SARS-CoV-2 vaccine has not been universally accepted. Similarly, vaccine related state regulations are heterogenous. We present a cross-sectional analysis of institutional specific vaccination policies at US pediatric renal transplant centers and relationships to state legislation. We found that 36.1% of institutions require COVID-19 vaccination prior to transplant, while 17 states have current legislation prohibiting proof of vaccination as a means of access to public services. Of the 63.9% of transplant centers without immunization requirement, almost two-thirds are located in states without prohibitory regulations. Despite an unclear primary influence of institutional policy, our study demonstrates a lack of standardization and potential to create unnecessary inequities.
鉴于其对死亡率的有益影响，肾移植仍然是儿童终末期肾病的理想治疗方式。尽管最近在幼儿中的使用范围有所扩大，但新型 SARS-CoV-2 疫苗尚未被普遍接受。同样，与疫苗相关的州法规也存在差异。我们对美国儿科肾移植中心的机构特定疫苗接种政策进行了横断面分析，并研究了其与州立法的关系。我们发现，36.1%的机构要求在移植前接种 COVID-19 疫苗，而 17 个州目前有立法禁止将疫苗接种证明作为获得公共服务的手段。在不需要免疫接种的 63.9%的移植中心中，几乎有三分之二位于没有禁止性规定的州。尽管机构政策的主要影响尚不明确，但我们的研究表明，这种情况缺乏标准化，并且可能会造成不必要的不平等。
